With just a couple of months until the EU Falsified Medicines Directive (FMD) comes into force, companies who have left it too late to implement their own serialization solution are now relying on support from third party providers, whose resources are in high demand.

In this article, our Director Corporate Strategy, Dexter Tjoa, discusses the timeframes associated with outsourcing serialization requirements and the importance of selecting well-prepared and trustworthy suppliers. Read the full article here: https://ubm.io/2EoPJdv